“Great things in business are never done by one person. They’re done by a team of people.” Steve Jobs
“Great things in business are never done by one person. They’re done by a team of people.” Steve Jobs
30+ years of experience and solid knowledge of the pharmaceutical industry. Available for you to solve pharmaceutical development issues. Together with technical know-how, there is plenty of experience in leadership and change management, which can also complement your organizational and resource needs.
Discover and use my expertise - drug development consulting services for pharmaceutical and biotechnology organizations.
Pharmaceutical development:
Conception and strategy development for active ingredients and products
Support and management of activities including preformulation, product development, scale up, tech transfer and validation
Support your teams and functions to reach the goals
Provide a second opinion and support technical evaluation and due diligence
Management support and consultancy in:
R&D leadership and management
Strategy development and implementation
Change management
Interim management services
Innovation and alliance management
I am a registered pharmacist with a doctorate degree in pharmaceutical technology from the university of Kiel.
Throughout my career, I held various positions in the pharmaceutical industry, starting as formulation scientist at Arzneimittelwerk Dresden GmbH in 1994, then joining Ferring Pharmaceuticals in 1996 where I finally led pharmaceutical development in Copenhagen.
In 2004, I took over pharmaceutical development at Schwarz Pharma, Germany. After the merger with UCB S.A. I became responsible for late phase drug product development.
In 2008, I joined Bayer as head of pharmaceutical development. 2012, I took up leadership for External Technology & Innovation, a new organization overseeing all external projects in drug product development. From 2014 onwards, I was leading the global alliance management function, supporting partnerships in drug discovery activities at Bayer Pharma. My last role before becoming independent was leading a project to carve out a significant part of the Bayer drug discovery in Berlin and transferring them to Nuvisan, becoming a drug discovery CRO.
In this undertaking, I was ultimately the managing director of this newly formed company until 2022.
During my career, I have worked with a broad range of products and dosage forms. Small molecules, peptides and protein drugs. Oral, transdermal, nasal, pulmonal and parenteral delivery in non-modified and modified forms. Furthermore, I was also involved in drug device development, product transfers, validations and post registration changes. I have led smaller and larger organizations, including virtual teams, and have extensive change management experience.
I have also been active in professional organizations.
I was member of the board of the APV from 2018-2022, member of the editorial board of the European Journal of Pharmaceutics and Biopharmaceutics for several years, vice president of the European Association Pharma Biotechnology (EAPB) and I supported PDA as member in organizing committees.
Throughout my career, these values have been fundamental:
It’s all about people
Relationship and reliability
Expertise and experience
Passion and flexibility.
Let us meet and talk.
Allow me to understand your challenges. This will help us both to formulate potential goals and to work out a plan together.
You can rely on solid support for your project and organization - I can flexibly adjust to your needs.
Let’s get in touch!